Abbas Hussain
Insider
First SEC filing: Sept. 3, 2020 · Latest: Sept. 3, 2020
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net: $-278,862
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | MRNA | A | 8,371 | · | · | 8,371 Direct | · | Acquired | (price as of 2026-10-05) |
| May 1, 2026 | MRNA | S 10b5-1 | 5,682 | $46.63 | $264,952 | 12,066 Direct | -32.01% | Disposed | 335.8% (price as of 2026-10-05) |
| April 30, 2026 | MRNA | M | 16,233 | · | · | 17,748 Direct | +1071.49% | Acquired | (price as of 2026-10-05) |
| April 30, 2026 | MRNA | M | 16,233 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Dec. 9, 2025 | MRNA | S 10b5-1 | 504 | $27.60 | $13,910 | 1,515 Direct | -24.96% | Disposed | 636.3% (price as of 2026-10-05) |
| Oct. 2, 2025 | MRNA | M | 1,439 | · | · | 2,019 Direct | +248.10% | Acquired | (price as of 2026-10-05) |
| Oct. 2, 2025 | MRNA | M | 1,439 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| June 11, 2025 | MRNA | S 10b5-1 | 312 | $28.00 | $8,736 | 580 Direct | -34.98% | Disposed | 625.8% (price as of 2026-10-05) |
| April 30, 2025 | MRNA | M | 892 | · | · | 892 Direct | · | Acquired | (price as of 2026-10-05) |
| April 30, 2025 | MRNA | A | 16,233 | · | · | 16,233 Direct | · | Acquired | (price as of 2026-10-05) |
| April 30, 2025 | MRNA | M | 892 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Oct. 2, 2024 | MRNA | A | 892 | · | · | 892 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 2, 2024 | MRNA | A | 1,439 | · | · | 1,439 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 2, 2024 | MRNA | A | 5,100 | · | · | 5,100 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 2, 2024 | MRNA | A | 8,093 | · | · | 8,093 Direct | · | Acquired | (price as of 2026-10-05) |
| June 14, 2021 | TEVA | A | 14,479 | · | · | 14,479 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 2, 2020 | TEVA | A | 13,050 | · | · | 13,050 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 8,371 | Acquired |
| April 30, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 16,233 | Disposed |
| Oct. 2, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 1,439 | Disposed |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 16,233 | Acquired |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 892 | Disposed |
| Oct. 2, 2024 | MRNA | Restricted Stock Units | Common Stock | · | · | 892 | Acquired |
| Oct. 2, 2024 | MRNA | Restricted Stock Units | Common Stock | · | · | 1,439 | Acquired |
| Oct. 2, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock | $63.16 | Oct. 2, 2034 | 5,100 | Acquired |
| Oct. 2, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock | $63.16 | Oct. 2, 2034 | 8,093 | Acquired |
| June 14, 2021 | TEVA | Restricted Share Units | Ordinary Shares [F3] | · | · | 14,479 | Acquired |
| Sept. 2, 2020 | TEVA | Restricted Share Units | Ordinary Shares [F3] | · | · | 13,050 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 3, 2020 | TEVA | Ordinary Shares [F1] | 0 | Direct |